We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Privacy Terms and Cookie Policy
Balanced Reporting. Trusted Insights.
Monday, April 07, 2025
The Food and Drug Administration is pushing back against a Memorandum of Understanding released Tuesday and designed to divide regulatory authority over genetically-engineered animals between USDA and FDA.
The Agriculture Department proposes to take over the Food and Drug Administration's oversight of gene-altered animals, a potential victory for livestock groups seeking to speed approval of genetic modifications.
The Trump administration is acting to remove another regulatory barrier to agricultural biotechnology by proposing to streamline EPA's oversight of pest-resistant plants. But there's little sign of progress on reforms to FDA’s regulation of gene-edited animals.
After 35 years at the Californian Department of Food and Agriculture, Dale Woods retires from the agency and AgBiome hires Jason Kuhlemeier as vice president of marketing.
Tim Hammerich joined Cogent Consulting and Communications as senior director of strategic communications and Scott Horsfall retires from the California Leafy Green Products Handler Marketing Agreement (LGMA).
David Hollinrake has been appointed to head of global seeds strategy and portfolio for Syngenta, and BIO tapped Michelle McMurry-Heath as the next president and CEO.
The COVID-19 pandemic highlights the need for an overhaul of the government's regulatory system for animal biotechnology products, the Biotechnology Innovation Organization said in a letter to President Donald Trump Tuesday.
Dana O'Brien stresses the need for Congress and the White House to pass One Health strategies and modernize America’s animal biotechnology regulatory approach with everything going on with COVID-19; two policies that are long overdue.